Versartis (VSAR) Earns Media Impact Score of 0.16
Media stories about Versartis (NASDAQ:VSAR) have been trending somewhat positive on Saturday, according to Accern Sentiment. The research firm identifies negative and positive news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Versartis earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave media stories about the biopharmaceutical company an impact score of 48.0995126330535 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
Shares of NASDAQ VSAR traded up $0.05 during midday trading on Friday, hitting $1.80. 204,148 shares of the company’s stock were exchanged, compared to its average volume of 543,944. The company has a debt-to-equity ratio of 0.11, a quick ratio of 16.99 and a current ratio of 16.99. Versartis has a twelve month low of $1.35 and a twelve month high of $22.10. The firm has a market capitalization of $62.51 million, a PE ratio of -0.75 and a beta of 1.89.
Versartis (NASDAQ:VSAR) last issued its earnings results on Tuesday, August 7th. The biopharmaceutical company reported ($0.27) earnings per share for the quarter, topping the consensus estimate of ($0.96) by $0.69. sell-side analysts forecast that Versartis will post -3.15 earnings per share for the current fiscal year.
In other news, Director Srinivas Akkaraju purchased 660,681 shares of the company’s stock in a transaction that occurred on Wednesday, June 6th. The shares were purchased at an average price of $1.74 per share, for a total transaction of $1,149,584.94. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In the last three months, insiders have bought 945,279 shares of company stock worth $1,725,673 and have sold 9,987 shares worth $15,585. 10.90% of the stock is currently owned by company insiders.
Versartis Company Profile
Read More: Marijuana Stocks Future Looks Bright
Receive News & Ratings for Versartis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versartis and related companies with MarketBeat.com's FREE daily email newsletter.